Disclosed is a functional drug injection module including: an injection unit including a body that is elongated, keeps a functional drug therein, has an outlet formed at a front end thereof, and is open at a rear end thereof, and a piston that is inserted in the body through the rear end of the body and discharges the functional drug by longitudinally sliding; a cover unit at least partially formed like a projection, inserted in the outlet, and adjust opening/closing of the outlet by selectively separating; and a sealing unit surrounding the injection unit and the cover unit, having a first crease formed in a longitudinal direction of the injection unit, and separating from the injection unit together with the cover unit by being divided along the first crease by external force.

A drug delivery system includes a drug delivery device that carries and delivers a drug. The system further includes a housing, and the housing includes a main body and a cover coupled to the main body. The main body includes a chamber that carries the drug delivery device and an opening coupled to the chamber. The cover is movable relative to the main body from a closed position to an open position. In the closed position the cover obscures the opening and thereby inhibits egress of the drug delivery device from the chamber via the opening, and in the open position the cover permits egress of the drug delivery device from the chamber via the opening. A lock-out mechanism is carried by the housing. The lock-out mechanism inhibits the cover from returning to the closed position after moving to the open position.

A method of treating episodic and chronic nasal congestion of the human nasal passages is disclosed. The present invention combines use of decongestant nasal spray, saline nasal spray, and nasal dilator therapies with minimized risk of incurring rebound congestion. The method may be used as both preventative and withdrawal therapies for patients experiencing rebound congestion. Nasal dilators, decongestant nasal spray and saline nasal spray are provided in kit form whereby users may practice the method.

Medical packaging is provided for enclosing a single-use medical device with multiple frangible operating lines and corresponding frangible connections to define a removable first end which reveals at the time of use an operative part forming the key part that is to come into contact with the patient. The remaining part of the device including the controlling part is retained in the rest of the packaging but can be used to control the device without hindrance. Each of the multiple frangible operating lines indicating on the packaging the difference between the key part that forms the operating part of the device for one of a plurality of predefined medical procedures wherein the identification of the frangible operating lines immediately educates and instructs the user in the correct usage in a sterile and clean manner.

A negative pressure wound therapy bandage for applying negative pressure to a wound, the bandage comprising: a membrane configured for disposition over a wound so as to form a wound chamber between the membrane and the wound, the membrane comprising a wound-side surface, an atmosphere-side surface, and an opening extending through the membrane from the wound-side surface to the atmosphere-side surface; and a pump assembly carried by the membrane, the pump assembly comprising: a pump body comprising a wall structure disposed about a pump chamber, wherein at least a portion of the wall structure is resilient, and further wherein the pump chamber communicates with the wound chamber through the opening formed in the membrane; and an atmosphere-side passageway extending through the wall structure so as to fluidically connect the pump chamber to the atmosphere.

A therapeutic vaporizer inhalation bag attachment system with an integrated valve is disclosed. The attachment system includes a body having a lumen extending between the two openings of the body, a bag coupling, and a valve positioned within the lumen. A method of using the inhalation bag attachment system is also disclosed.

A packaging system for microarrays, such as microarrays of microneedles, comprising inner and outer pouches (500, 5000).

A PRP harvesting kit for harvesting platelet rich plasma that includes one or more collection tubes, each collection tube includes liquid biotin in an injectable form.

A universal respiratory detector for detecting a respiratory gas. The universal respiratory detector may include a plurality of layers with a visual indicator to quickly and reversibly change color to detect a respiratory gas parameter such as carbon dioxide. The color change may be visible from both sides of the detector. In some examples, the respiratory detector may be a biocompatible and conformable sticker for mounting on a person's face or an oxygen delivery device.

A system may include an external device and an inhaler. The external device may include a processor, a communication circuit, and memory. The inhaler may include a mouthpiece, medicament, a mechanical dose counter, and an electronics module comprising a processor and a communication circuit. The electronics module may record a dosing event when the inhaler is actuated, such as when the mouthpiece cover is opened, and send a signal indicating the dosing event to the external device. The external device may receive a mechanical dose reading of the mechanical dose counter, determine an electronic dose reading based on the signal indicating the dosing event, determine that a discrepancy between the mechanical dose reading and the electronic dose reading exceeds a threshold, and notify the user of the discrepancy, for example, by providing a notification to the user by way of a mobile application residing on the external device.